Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer-Reference-Cited by-同舟云学术

Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer

Published:2017-01-06 Issue:4 Volume:30 Page:577-586
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Enwere Emeka K,Kornaga Elizabeth N,Dean Michelle,Koulis Theodora A,Phan Tien,Kalantarian Maria,Köbel Martin,Ghatage Prafull,Magliocco Anthony M,Lees-Miller Susan P,Doll Corinne M

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2016221.pdf

Reference41 articles.

1. Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–E386.

2. Minig L, Patrono MG, Romero N, et al. Different strategies of treatment for uterine cervical carcinoma stage IB2-IIB. World J Clin Oncol 2014;5:86–92.

3. Chemoradiotherapy for Cervical Cancer Meta-Analysis C. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802–5812.

4. Trivedi MS, Hoffner B, Winkelmann JL et al. Programmed death 1 immune checkpoint inhibitors. Clin Adv Hematol Oncol 2015;13:858–868.

5. Brahmer JR, Tykodi SS, Chow LQ et al, Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012;366:2455–2465.

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced, recurrent, and persistent cervical cancer management: in the era of immunotherapy;Frontiers in Oncology;2024-08-05

2. The evolution of treatment for advanced cervical cancer: from cisplatin monotherapy to immuno-oncology combinations;Meditsinskiy sovet = Medical Council;2024-07-24

3. The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer;Cancer Drug Resistance;2024-06-11

4. PD-L1 expression in squamous cervical carcinomas of Mozambican women living with or without HIV;Scientific Reports;2024-06-05

5. Updates in the Use of Targeted Therapies for Gynecologic Cancers;American Society of Clinical Oncology Educational Book;2024-06